Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Public advisory - Unauthorized health products seized from Vanette Keast Health Consulting in Red Deer, Alberta may pose serious health risks


OTTAWA, ON, April 9, 2024 /CNW/ -

Summary

Images

Affected products

Product

Health risk

AMSA Laboratorios Metformina Oral Tablets

Labelled to contain metformin hydrochloride

Janssen Vermox Plus Oral Tablets

Labelled to contain mebendazole

Julia T. Hunter M.D. Wholistic Dermatology Skin Physiology DHEA Support Topical Cream

Labelled to contain DHEA

Julia T. Hunter M.D. Wholistic Dermatology Skin Physiology Estriol Estrogen Support Topical Cream

Labelled to contain estriol

Julia T. Hunter M.D. Wholistic Dermatology Skin Physiology Progesterone Support Topical Cream

Labelled to contain progesterone

Maver Veridex Ivermectina Oral Tablets

Labelled to contain ivermectin

Merk Eutirox Levotiroxina Sodica Oral Tablets

Labelled to contain levothyroxine sodium

Physica Energetics Pregnenolone Liposomal Oral Drops

Labelled to contain DHEA

Premier Labs Canada Enhanced Thyroid Complex Oral Capsule

Labelled to contain thyroid (also known as levothyroxine sodium)

Sintrocid Levotiroxina Sodica Oral Tablets

Labelled to contain levothyroxine sodium

Skin Fitness Plus Thyroid Support Oral Capsule

Labelled to contain thyroid (also known as levothyroxine sodium)

Tecnofarma Ivermectina Oral Tablets

Labelled to contain ivermectin

Water Treatment Drink Mix (28%)

Labelled to contain sodium chlorite

Issue

Health Canada is warning consumers about multiple unauthorized health products seized from Vanette Keast Health Consulting in Red Deer, Alberta, after the Department was informed that the company was importing unauthorized prescription drugs. The seized products are labelled to contain prescription, controlled or other drug ingredients, and may pose serious health risks. The products are promoted for various uses, including as treatments for diabetes, parasites or hypothyroidism. One product is a drink mix that contains sodium chlorite, which may pose serious health risks if ingested.

Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.

Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription.

What you should do

Background

DHEA (dehydroepiandrosterone) is a controlled substance regulated under the Controlled Drugs and Substances Act that can cause higher-than-normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian and other hormone-sensitive cancers. Potential side effects include serious cardiovascular disease, and changes in fertility and sperm production. DHEA should be avoided by individuals with a history of abnormal heart rhythms, blood clotting disorders, liver disease and those who are pregnant or breastfeeding.

Estriol is a type of estrogen that has not been authorized in Canada. Drug products containing estrogens should not be used in patients allergic to estrogens, patients with endometrial hyperplasia (thickening of the uterine lining), unexplained vaginal bleeding, hormone-dependent cancers (including a history of breast cancer), clotting disorders, heart or liver disorders, migraines, or in pregnant people. The use of drug products containing estrogens might cause serious side effects including abnormal vaginal bleeding, blood clots in the veins of the legs or lungs, cancers in the breast or uterus, strokes or heart attack.

Ivermectin is a prescription drug used to treat certain parasitic worm infections. Ivermectin can be associated with serious side effects, particularly if taken at high doses. These side effects include low blood pressure, dizziness, severe allergic reactions, worsening of asthma, liver problems, and decreased alertness including coma.

Levothyroxine sodium is a prescription drug which is commonly used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. Levothyroxine products should not be used by patients allergic to levothyroxine, patients with adrenal glands not producing enough of the hormone cortisol, those whose thyroid gland produces too much thyroxine, and patients with a recent heart attack or heart inflammation. Pregnant people should not use levothyroxine unless recommended by a physician. Levothyroxine products can cause serious or life-threatening side effects, including fast or irregular heart beats and respiratory difficulty, and patients with previous heart diseases, high blood pressure, and older patients are more at risk. Levels of levothyroxine in the blood can quickly rise to toxic levels, which can occur even faster if the patient is already taking certain other medicines. Levothyroxine should not be used to lose weight or to treat obesity.

Mebendazole is a prescription drug used to treat certain parasitic worm infections. Mebendazole can be associated with serious side effects, particularly if taken at high doses. These side effects include severe allergic reactions, blood, liver and kidney disorders, and seizures. Use of mebendazole should be avoided in infants, patients who are pregnant, and patients taking drugs containing metronidazole.

Metformin hydrochloride is a prescription drug which is used to treat type 2 diabetes. Metformin should not be used in patients who have insulin-dependent diabetes, also known as Type I diabetes, patients with renal insufficiency or liver disease, those who have had a diagnosis of lactic acidosis (too much lactic acid in the blood), patients who abuse alcohol, patients with severe dehydration, or those experiencing stress conditions (including infection, trauma). Metformin should not be used by pregnant or breastfeeding people, unless recommended by their doctor. This drug should not be taken if the patient is undergoing surgery or having an X-ray procedure with dye injected into a vein. Metformin might cause side effects, especially diarrhea, nausea, abdominal pain, vomiting, and a life-threatening condition called lactic acidosis, which is characterized by low body temperature, low blood pressure, and slow heart rate.

Progesterone is a prescription drug and can be associated with serious side effects, particularly in patients at risk of blood clots or patients with hormone-dependent cancers. Progesterone may also affect liver function and/or glucose tolerance. Patients who are also taking oral progesterone-containing medications (such as birth control pills or hormone replacement therapy) may be at an increased risk due to effects of the combined progesterone exposure in the body. For topical progesterone products, health risks may arise after long-term use.

Sodium Chlorite is commonly used for bleaching textiles, pulp and paper, surface disinfectant and for water treatment. No health products containing sodium chlorite have been approved by Health Canada for human consumption. Ingesting sodium chlorite may cause serious health problems including poisoning, kidney failure and harm to red blood cells that reduces the ability of the blood to carry oxygen. Additional health problems may also include abdominal pain, nausea, vomiting, and diarrhea.

SOURCE Health Canada (HC)


These press releases may also interest you

at 16:36
Richards Packaging Income Fund (the "Fund") announced that the five nominees listed in the management information circular for the 2024 Annual Meeting of Unitholders were elected as Trustees of the Fund at the annual general meeting held in Toronto,...

at 16:34
An Illinois utility watchdog group has joined forces with a community that has had highly publicized problems with lead in its drinking water to file testimony arguing that Aqua Illinois' proposed $19.2 million rate hike should be slashed by at least...

at 16:30
Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data highlight multiple ascending dose safety, bioactivity...

at 16:30
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased...

at 16:30
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report first quarter 2024 financial results on Wednesday, May 8, 2024. Karyopharm's management team will host a...

at 16:20
Sangamo Therapeutics, Inc. , a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. The company will hold a conference...



News published on and distributed by: